Utama › Kolitis Ulseratif › Illinois › Chicago
Kajian klinikal Kolitis Ulseratif di Chicago, IL
15 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Mengambil pesertaFasa 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Mengambil pesertaFasa 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Mengambil pesertaFasa 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mengambil pesertaFasa 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Mengambil pesertaFasa 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Mengambil pesertaFasa 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Mengambil pesertaFasa 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Mengambil peserta
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Mengambil pesertaKajian pemerhatian
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Mengambil pesertaFasa 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Mengambil pesertaFasa 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Mengambil peserta
- University of Chicago, Chicago
Kajian Kolitis Ulseratif di bandar lain
- New York City, NY23 kajian
- Orlando, FL22 kajian
- Miami, FL21 kajian
- Houston, TX17 kajian
- San Antonio, TX16 kajian
- Tacoma, WA15 kajian
- San Diego, CA15 kajian
- Tyler, TX14 kajian
- Colorado Springs, CO14 kajian
- Los Angeles, CA13 kajian
- St. Louis, MO13 kajian
- Washington, DC12 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.